Junnan Xu

2.9k total citations · 1 hit paper
100 papers, 2.2k citations indexed

About

Junnan Xu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Food Science. According to data from OpenAlex, Junnan Xu has authored 100 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 18 papers in Food Science. Recurrent topics in Junnan Xu's work include Neuroscience and Neuropharmacology Research (18 papers), Gut microbiota and health (14 papers) and Ion Transport and Channel Regulation (9 papers). Junnan Xu is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Gut microbiota and health (14 papers) and Ion Transport and Channel Regulation (9 papers). Junnan Xu collaborates with scholars based in China, United States and Australia. Junnan Xu's co-authors include Leif Hertz, Dan Song, Mingtao Fan, Liang Peng, Xinyuan Wei, Tao Sun, Yundai Chen, Yue Wang, Feng Tian and Ying Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Junnan Xu

96 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Melatonin attenuates myocardial ischemia‐reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK‐OPA1 signaling pathways

2018 335 citations Junnan Xu et al. profile →

Peers

Countries citing papers authored by Junnan Xu

Since Specialization

Citations

This map shows the geographic impact of Junnan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junnan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junnan Xu more than expected).

Fields of papers citing papers by Junnan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junnan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junnan Xu. The network helps show where Junnan Xu may publish in the future.

Co-authorship network of co-authors of Junnan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junnan Xu. A scholar is included among the top collaborators of Junnan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junnan Xu. Junnan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural insights into cationic amino acid transport and viral receptor engagement by CAT1 2025 ·Nature Communications ·(unknown), (unknown), R. Zou, (unknown), Junnan Xu, Yan Pan, Yuan Yuan, Shuo Li, Yang Yang, Xuemin Chen	1
2	Recent advances in copper sulfide nanoparticles for cancer diagnosis and therapy 2025 ·Materials Today Bio ·(unknown), (unknown), Zhangrong Lou, Junnan Xu, Yiwen Ma, Xiaorui Li, Qiang Liu, Tao Sun	0
3	Increased distribution of carbon metabolic flux during de novo cytidine biosynthesis via attenuation of the acetic acid metabolism pathway in Escherichia coli 2025 ·Microbial Cell Factories ·Tong Ye, Wei Ding, (unknown), Haojie Zhang, Xiaobo Wei, Junnan Xu, Huiyan Liu, Haitian Fang	5
4	Integrated transcriptomics, metabolomics and physiological analyses reveal the regulatory mechanisms of ABA and MeJA treatments on quality deterioration of wounded kiwifruit fruits 2025 ·Postharvest Biology and Technology ·(unknown), (unknown), (unknown), Huili Zhang, Yaoran Li, Junnan Xu, Wei Ding, Huiyan Liu, Haitian Fang, Xiaobo Wei	0
5	Promoting cytidine biosynthesis by modulating pyrimidine metabolism and carbon metabolic regulatory networks in Bacillus subtilis 2025 ·Microbial Cell Factories ·Xiangjun Zhang, Lu Liu, (unknown), Tong Ye, Wei Ding, Xiaobo Wei, Junnan Xu, Haitian Fang, Huiyan Liu	2
6	Highly specific vaginal microbiome signature for gynecological cancers 2024 ·Open Life Sciences ·Mengzhen Han, Na Wang, (unknown), Xiaolin Liu, Tao Sun, Junnan Xu	1
7	Intratumoral and fecal microbiota reveals microbial markers associated with gastric carcinogenesis 2024 ·Frontiers in Cellular and Infection Microbiology ·Yiwen Wang, (unknown), (unknown), Mengzhen Han, Xiaolin Liu, (unknown), Yuesheng Dong, Tao Sun, Junnan Xu	10
8	Exploring gut microbiome markers in predicting efficacy of immunotherapy against lung cancer. 2024 ·Journal of Clinical Oncology ·(unknown), Junnan Xu, Tao Sun, Yuhang Zhou, Yun Feng, Han Li, Xiaolin Liu	0
9	Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer 2024 ·Therapeutic Advances in Medical Oncology ·(unknown), Junnan Xu, (unknown), (unknown), (unknown), Tao Sun	2
10	Cytoprotection of probiotics by nanoencapsulation for advanced functions 2023 ·Trends in Food Science & Technology ·Tong Zhang, Congdi Shang, Ting Du, Junchen Zhuo, Chen Wang, Bing‐Zhi Li, Junnan Xu, Mingtao Fan, Jianlong Wang, Wentao Zhang	21
11	Vaginal and tumor microbiomes in gynecological cancer (Review) 2023 ·Oncology Letters ·Mengzhen Han, Na Wang, (unknown), (unknown), Tao Sun, Junnan Xu	11
12	Contribution of amino acids to Alicyclobacillus acidoterrestris DSM 3922T resistance towards acid stress 2023 ·Food Microbiology ·Junnan Xu, Ning Zhao, Xuemei Meng, Tong Zhang, Jun Li, (unknown), Xinyuan Wei, Mingtao Fan	14
13	The role of microbiota in the development and treatment of gastric cancer 2023 ·Frontiers in Oncology ·Yiwen Wang, (unknown), Na Wang, Mengzhen Han, (unknown), (unknown), Yuesheng Dong, Tao Sun, Junnan Xu	16
14	Breast cancer brain metastasis: Current evidence and future directions 2022 ·Cancer Medicine ·(unknown), Junnan Xu, Shuang Dai, (unknown), Tao Sun	36
15	Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists 2021 ·BMC Psychiatry ·(unknown), Junnan Xu, Li Cai, Man Li, Limin Niu, Juan Hu, Tao Sun, Xinyu Zheng	7
16	Autophagic Vacuole Secretion Triggered by Chidamide Participates in TRAIL Apoptosis Effect in Breast Cancer Cells 2020 ·Current Pharmaceutical Design ·Weiqiang Zhou, (unknown), Junnan Xu, Tao Sun, (unknown)	7
17	<p>Identification of Aurora Kinase A as a Biomarker for Prognosis in Obesity Patients with Early Breast Cancer</p> 2020 ·OncoTargets and Therapy ·(unknown), (unknown), Junnan Xu, Tao Sun, Xinyu Zheng	7
18	Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial 2020 ·Trials ·(unknown), Liang Zhang, Huan Li, Junnan Xu, Cui Jiang, Tao Sun	8
19	Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway 2019 ·Journal of Cellular Physiology ·(unknown), Junnan Xu, Xiaoli Li, Zhijia Liu, Yong Han, Xiaoguang Xu, Xiubin Li, Yuzhe Tang, Yubao Liu, (unknown), Xiang Li	81
20	Effects of Bailing capsule on diabetic nephropathy based on UPLC-MS urine metabolomics 2019 ·RSC Advances ·Junnan Xu, Qing Yuan, Kang Wu, Xiubin Li, (unknown), Yuanyu Zhao, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact